Inzy stock forecast.

Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceNov 29, 2023 · Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts. The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Inozyme Pharma Inc have a median target of 16.00, with a high estimate of 40.00 and a low estimate of 15.00. The median ...

According to 42 stock analysts, the average 12-month stock price forecast for Amazon stock is $170.76, which predicts an increase of 16.14%. The lowest target is $116 and the highest is $230. On average, analysts rate Amazon stock as a strong buy. Analyst Consensus: Strong Buy. Target Low Average Median High; Price: $116: $170.76: …566.33%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -1.63M. -77.72%. Get the latest Immix Biopharma Inc (IMMX ...Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $12.95B. -12.7%. Market Cap / Employee. The market cap of a ...

Based on 12 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $82.64 with a high forecast of $93.00 and a low forecast of $63.00. The average price target represents a 53.24% change from the last price of $53.93. Highest Price Target $93.00. Average Price Target $82.64.Nov 29, 2023 · See the latest Incyte Corp stock price (INCY:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Federated Hermes: bullish, S&P 500 price target of 5,000. Strong underlying trends in the stock market are likely to extend well into 2024, according to Federated …Based on 12 Wall Street analysts offering 12 month price targets for Incyte in the last 3 months. The average price target is $82.64 with a high forecast of $93.00 and a low forecast of $63.00. The average price target represents a 53.24% change from the last price of $53.93. Highest Price Target $93.00. Average Price Target $82.64.The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...Get the latest Inozyme Pharma Inc (INZY) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financial results, market news, and earnings per share for the fiscal Q2 2023 ended 6/30/23. Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level. Try it Free. Find the latest Incyte Corporation (INCY) stock forecast based ...

The firm owned 605,555 shares of the company’s stock after selling 69,848 ... Equities analysts forecast that Dynatrace, Inc. will post 0.58 ... INZY) Rock Springs Capital Management ...

INZY Overview Stock Screener Earnings Calendar Sectors Nasdaq | INZY U.S.: Nasdaq Inozyme Pharma Inc. Watch NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 6:44 p.m. EST...

According to the SEC filings submitted on Wednesday and Thursday, Hopfner has raised his stake at Inozyme ( INZY) to 3.2M shares after buying ~207.8K and ~344.5K company stock at $4.05 and $4.54 ...Incyte has risen higher in 16 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.33%. Is Incyte Stock Undervalued? The current Incyte [ INCY] share price is $53.39. The Score for INCY is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.Find out why INZY stock is a Hold. ... In a pre-revenue phase, evident by the consistent zero sales forecast, their growth is underpinned by the developmental stage of their drug, INZ-701 ...For Sorrento Therapeutics stock forecast for 2023, 8 predictions are offered for each month of 2023 with average Sorrento Therapeutics stock forecast of $0.76, a high forecast of $1.2, and a low forecast of $0.36. The average Sorrento Therapeutics stock forecast 2023 represents a 127.59% increase from the last price of $0.332199990749359.Axsome Therapeutics stock price target raised to $76 from $49 at Mizuho. Sep. 7, 2022 at 6:38 a.m. ET by Tomi Kilgore.Find the latest Incyte Corporation (INCY) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo FinanceYou can buy or sell Inozyme Pharma and other ETFs, options, and stocks. View the real-time INZY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule ...

What is the current Price Target and Forecast for Inozyme Pharma (INZY) Inozyme Pharma (INZY) (Delayed Data from NSDQ) $3.93 USD +0.23 (6.22%) Updated Nov 24, 2023 01:00 PM ET After-Market:...Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.The Walt Disney Company (NYSE:DIS) posted its earnings results on Wednesday, November, 8th. The entertainment giant reported $0.82 earnings per share for the quarter, beating analysts' consensus estimates of $0.67 by $0.15. The entertainment giant earned $21.24 billion during the quarter, compared to analysts' expectations of …Incyte Corp. Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib).Find the latest analyst research for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com ... Forecast Changes; ... Analysts evaluate the stock’s expected performance in a given ...

But that wasn’t the same sentiment insiders shared. CEO Malhotra and Director Robert Jordan collectively nabbed roughly $100,000 worth of TCS stock at average prices ranging from $2.569 to $2.63. Malhotra accounted for most of the buying, with more than 29,000 shares purchased, totaling around $76,000.

INZY stock had a strong performance on September 27, 2023, based on the information provided by CNN Money. The 12-month price forecasts from 6 analysts for Inozyme Pharma Inc have a median target of $16.00, with a high estimate of $40.00 and a low estimate of $15.00.Inozyme Pharma Inc (NASDAQ:INZY) trade information. After registering a 7.80% upside in the last session, Inozyme Pharma Inc (INZY) has traded red over the past five days. The stock hit a weekly high of 3.21 this Friday, 11/03/23, jumping 7.80% in its intraday price action. The 5-day price performance for the stock is 17.34%, and -14.97% over ...Find the latest Kintara Therapeutics, Inc. (KTRA) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock analysis for Inozyme Pharma Inc (INZY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.2 days ago · Complete Inozyme Pharma Inc. stock information by Barron's. View real-time INZY stock price and news, along with industry-best analysis. Nov 22, 2023 · Incyte Corp (INCY) Stock Forecast: Potential 33% Increase According to Analysts. On November 22, 2023, Incyte Corp (INCY) stock had a median target price forecast of $71.00, according to 18 analysts surveyed by CNN Money. The high estimate for the stock price was $93.00, while the low estimate was $58.00. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ...

A high-level overview of BigBear.ai Holdings, Inc. (BBAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Find the latest Inozyme Pharma, Inc. (INZY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Kintara Therapeutics, Inc. (KTRA) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest analyst research for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com ... Forecast Changes; ... Analysts evaluate the stock’s expected performance in a given ...A shelf registration statement on Form S-3 (File No. 333-258702) relating to the shares of common stock offered in the public offering was filed with the Securities and Exchange Commission (the ...Price Action: INZY shares are up 26.6% at $2.81 during the premarket session on the last check Thursday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free!Find the latest Avenue Therapeutics, Inc. (ATXI) stock quote, history, news and other vital information to help you with your stock trading and investing.Incyte stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Incyte analysts is $ 76.35. Today 200 Day Moving Average is the resistance level (65.46 $). 50 Day Moving Average is the resistance level (56.93 $).Inozyme Pharma, Inc. Common Stock (INZY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Sep 20, 2023 · Inozyme Pharma, Inc. (INZY) share price prediction for 2023, 2024, 2025, 2026 and 2027. INZY one year forecast. Inozyme Pharma stock monthly and weekly forecasts. Join Seeking Alpha, the largest investing community in the world. Get stock market news and analysis, investing ideas, earnings calls, charts and portfolio analysis tools.Find the latest Spyre Therapeutics, Inc. (AGLE) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest Inozyme Pharma Inc. (INZY) stock price, news, historical charts, analyst ratings and financial information from WSJ.Aug 9, 2023 · For the current quarter, INZY is expected to report an EPS forecast of -$0.45. In terms of annual financials, INZY reported an annual revenue of $0.00 for the last year and an annual profit of -$67.1 million. INZY Stock Shows Promising Performance on August 9, 2023: Optimistic Price Forecasts and Unanimous Buy Rating. INZY stock, belonging to ...

INZY Stock 12 Months Forecast. $16.00. (315.58% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Inozyme Pharma in the last 3 months. The average price target is $16.00 with a high forecast of $16.00 and a low forecast of $16.00. The average price target represents a 315.58% change from the last price of $3.85. A shelf registration statement on Form S-3 (File No. 333-258702) relating to the shares of common stock offered in the public offering was filed with the Securities and Exchange Commission (the ...Find the latest Institutional Holdings data for Inozyme Pharma, Inc. Common Stock (INZY) at Nasdaq.com.Instagram:https://instagram. efas stockdividend stocks to buyis the stock market overvaluedoplx stock For Sorrento Therapeutics stock forecast for 2023, 8 predictions are offered for each month of 2023 with average Sorrento Therapeutics stock forecast of $0.76, a high forecast of $1.2, and a low forecast of $0.36. The average Sorrento Therapeutics stock forecast 2023 represents a 127.59% increase from the last price of $0.332199990749359. jupw stocktwitsfidelity practice trading account Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you. meta stock predictions Find the latest Oncolytics Biotech Inc. (ONCY) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest INZY earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. ... Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine.